Last updated: 2026-09-16 10:31:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Assertio Holdings, Inc. (ASRT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Assertio Holdings, Inc. (ASRT) is trading at $-- in pre-market trading as of --, -- from the previous close of $--
Pre-market trading shows how investors are pricing ASRT before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, Assertio Holdings, Inc. (ASRT) moved from $23,45 to $23,50, representing a gain of 0,21% ($0,05).
The stock traded between $23,43 and $23,50 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 446,90 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Assertio Holdings Inc is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients' needs. The group's focus is on supporting patients by marketing oncology, neurology, and pain management products.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 53 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Assertio Holdings, Inc. (ASRT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.